Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription 13.05.2024 2 BMJ 1 Infect Immun 1 J Infect 3 J Infect Dis 2 JAMA 1 Lancet 1 Pediatr Infect Dis J 1 Pediatrics 14 PLoS One 1 Science 30 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. KMIETOWICZ Z
   Whooping cough: Five infants die in England this year as cases continue to rise.
   BMJ. 2024;385:q1059.
   PubMed        
   
   
2. NAKWEYA G
   Moderna's decision to shelve vaccine plant in Kenya should encourage global south's self-reliance, says global health adviser.
   BMJ. 2024;385:q1051.
   PubMed        
   
   

   
   Infect Immun

3. IHARA S, Nguyen BV, Miyamoto Y, Eckmann L, et al
   Mucosal vaccination in a murine gnotobiotic model of Giardia lamblia infection.
   Infect Immun. 2024 May 9:e0006524. doi: 10.1128/iai.00065.
   PubMed         Abstract available
   
   

   
   J Infect

4. KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
   Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
   J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
   PubMed         Abstract available
   
   

   
   J Infect Dis

5. PERSSON KEM, Horton JL, Kurtovic L, McCarthy JS, et al
   Declining antibody affinity over time after human vaccination with a Plasmodium falciparum merozoite vaccine candidate.
   J Infect Dis. 2024 May 9:jiae259. doi: 10.1093.
   PubMed         Abstract available
   
   
6. EBINGER JE, Sun N, Joung SY, Sanchez JMS, et al
   Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following Prior Infection or Vaccination.
   J Infect Dis. 2024 May 8:jiae130. doi: 10.1093.
   PubMed         Abstract available
   
   
7. BALASINGAM S, Dheda K, Fortune S, Gordon SB, et al
   Review of the current TB human infection studies for use in accelerating TB vaccine development: A meeting report.
   J Infect Dis. 2024 May 6:jiae238. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   JAMA

8. HARRIS E
   National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
   JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
   PubMed        
   
   
9. HARRIS E
   Five-in-One Meningitis Vaccine Rolls Out.
   JAMA. 2024 May 10. doi: 10.1001/jama.2024.7727.
   PubMed        
   
   

   
   Lancet

10. SHATTOCK AJ, Johnson HC, Sim SY, Carter A, et al
    Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.
    Lancet. 2024 May 2:S0140-6736(24)00850-X. doi: 10.1016/S0140-6736(24)00850.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

11. MAYTUM A, Porter D, de Whalley P, Thompson A, et al
    The Impact of Infant Bacille Calmette-Guerin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
    Pediatr Infect Dis J. 2024 May 8. doi: 10.1097/INF.0000000000004373.
    PubMed         Abstract available
    
    

    
    Pediatrics

12. MORO PL, Scheffey A, Gallego R, Jones JM, et al
    Incorrect Administration of Adult RSV Vaccines to Young Children.
    Pediatrics. 2024;153:e2024066174.
    PubMed        
    
    

    
    PLoS One

13. CHENG MC, Lai GH, Tsai YL, Lien YY, et al
    Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene.
    PLoS One. 2024;19:e0303371.
    PubMed         Abstract available
    
    
14. KUMAR A, Misra G, Mohandas S, Yadav PD, et al
    Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus.
    PLoS One. 2024;19:e0300507.
    PubMed         Abstract available
    
    
15. RAMOS A, Martins S, Marinho AS, Norton P, et al
    Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
    PLoS One. 2024;19:e0303244.
    PubMed         Abstract available
    
    
16. CHOI Y, Kim IK, Kim SJ, Kim HS, et al
    Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
    PLoS One. 2024;19:e0303050.
    PubMed         Abstract available
    
    
17. RAJOROMANANA B, Nyirenda G, Edosoa GT, Andrianasolo RL, et al
    Dog ecology and rabies control including canine vaccination coverage: Impacts from a survey in Madagascar.
    PLoS One. 2024;19:e0302690.
    PubMed         Abstract available
    
    
18. BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
    Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
    PLoS One. 2024;19:e0300731.
    PubMed         Abstract available
    
    
19. NOUR D, Ismail MB, Osman M, Rafei R, et al
    Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
    PLoS One. 2024;19:e0302579.
    PubMed         Abstract available
    
    
20. AGGARWAL S, Singh L, Alam U, Sharma S, et al
    COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    PLoS One. 2024;19:e0294480.
    PubMed         Abstract available
    
    
21. OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
    COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
    PLoS One. 2024;19:e0303172.
    PubMed         Abstract available
    
    
22. VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
    How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
    PLoS One. 2024;19:e0303043.
    PubMed         Abstract available
    
    
23. IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
    BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
    PLoS One. 2024;19:e0302722.
    PubMed         Abstract available
    
    
24. 
    Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
    PLoS One. 2024;19:e0303549.
    PubMed        
    
    
25. WHELAN AO, Flick-Smith HC, Walker NJ, Abraham A, et al
    A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
    PLoS One. 2024;19:e0294998.
    PubMed         Abstract available
    
    
26. KIM S, Lilani A, Redemptus C, Campana K, et al
    A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    PLoS One. 2024;19:e0300206.
    PubMed         Abstract available
    
    

    
    Science

27. ROBERTS L
    Report offers harsh verdict on global polio vaccine switch.
    Science. 2024;384:608-609.
    PubMed         Abstract available
    
    

    
    Vaccine

28. KIM DH, Lee SH, Kim J, Lee J, et al
    Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks.
    Vaccine. 2024 May 8:S0264-410X(24)00527-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
29. LAURA SORIANO PEREZ M, Montironi I, Alejandro Funes J, Margineda C, et al
    Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species.
    Vaccine. 2024 May 7:S0264-410X(24)00525-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
30. BASKOL ELIK D, Yildirim C, Akyol Seyhan D, Aytac Erdem H, et al
    Evaluation of antibody responses in healthcare workers before & after meningococcal vaccine and determination of meningococcal carriage rates.
    Vaccine. 2024 May 7:S0264-410X(24)00540-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
31. TIPPINS A, Acevedo JC, Palomeque FS, Coy KC, et al
    Strategies to strengthen COVID-19 vaccine uptake and improve vaccine equity in U.S. Territories and Freely Associated States during the first six months of vaccine rollout.
    Vaccine. 2024 May 7:S0264-410X(24)00541-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
32. DIONNE M, Etienne D, Witteman HO, Sauvageau C, et al
    Impact of interventions to improve HPV vaccination acceptance and uptake in school-based programs: Findings of a pilot project in Quebec.
    Vaccine. 2024 May 6:S0264-410X(24)00528-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
33. CAO A, Ueta M, Uchibori M, Murakami M, et al
    Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan.
    Vaccine. 2024 May 6:S0264-410X(24)00520-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
34. SONG H, Waheed Abdullah S, Yin S, Dong H, et al
    Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs.
    Vaccine. 2024 May 6:S0264-410X(24)00530-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
35. SOE P, Wong H, Naus M, Muller MP, et al
    mRNA COVID-19 vaccine safety among older adults from the Canadian National Vaccine Safety Network.
    Vaccine. 2024 May 6:S0264-410X(24)00535-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
36. JEARANAIWITAYAKUL T, Sunintaboon P, Kittiayuwat A, Limthongkul J, et al
    Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development.
    Vaccine. 2024 May 6:S0264-410X(24)00519-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
37. KOLAKOWSKA A, Marshall E, Krastinova E, Cros A, et al
    Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: A prospective study in outpatient clinics in the Paris region.
    Vaccine. 2024 May 6:S0264-410X(24)00516-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
38. KIM J, Chang J
    Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.
    Vaccine. 2024 May 6:S0264-410X(24)00481-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
39. LI H, Li Q, Hao Z, Zhang L, et al
    A recombinant IL-1beta vaccine attenuates bleomycin-induced pulmonary fibrosis in mice.
    Vaccine. 2024 May 6:S0264-410X(24)00531-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
40. CROWE CL, Dreyfus J, Lanes S, Chung H, et al
    Variation in incidence rates of outcomes relevant to vaccine safety monitoring in a US commercially insured population by case identification algorithm.
    Vaccine. 2024 May 6:S0264-410X(24)00534-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
41. EHRLICH KB, Lyle SM, Corallo KL, Lavner JA, et al
    Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults.
    Vaccine. 2024 May 2:S0264-410X(24)00505-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
42. DHALARIA P, Kumar P, Verma A, Priyadarshini P, et al
    Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
    Vaccine. 2024 May 3:S0264-410X(24)00511-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
43. ANGAITKAR P, Ram Janghel R, Prasad Sahu T
    An MCDM approach for Reverse vaccinology model to predict bacterial protective antigens.
    Vaccine. 2024 May 3:S0264-410X(24)00517-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
44. LAMBACH P, Silal S, Sbarra AN, Koh M, et al
    Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024.
    Vaccine. 2024 May 3:S0264-410X(24)00494-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
45. HU H, Ma F, Gong L, Wang Y, et al
    Immunogenicity and safety of a recombinant Omicron BA.4/5-Delta COVID-19 vaccine ZF2202-A in Chinese adults.
    Vaccine. 2024 May 3:S0264-410X(24)00495-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
46. MARINTHE G, Brown G, Cristea M, Kutlaca M, et al
    Predicting vaccination hesitancy: The role of basic needs satisfaction and institutional trust.
    Vaccine. 2024 May 3:S0264-410X(24)00507-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
47. MERTENS JE, Rigby CA, Bardelli M, Quinkert D, et al
    Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
    Vaccine. 2024 May 3:S0264-410X(24)00514-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
48. BAGLIVO F, De Angelis L, Magri M, De Nicola I, et al
    The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents' attitudes towards mandatory and recommended vaccination in Southern Italy.
    Vaccine. 2024 May 3:S0264-410X(24)00513-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
49. BENEDICT KPOZEHOUEN E, Macintyre CR, Tan TC
    Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Vaccine. 2024 May 3:S0264-410X(24)00445-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
50. SEFAT KMSR, Kumar M, Kehl S, Kulkarni R, et al
    An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Vaccine. 2024 May 3:S0264-410X(24)00482-1. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
51. MAUREL M, Mazagatos C, Goerlitz L, Oroszi B, et al
    Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
    Vaccine. 2024 May 3:S0264-410X(24)00497-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
52. SHI XC, Gruber JF, Ondari M, Lloyd PC, et al
    Assessment of potential adverse events following the 2022-2023 seasonal influenza vaccines among U.S. adults aged 65 years and older.
    Vaccine. 2024 May 3:S0264-410X(24)00478-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
53. ESPARZA J
    Introduction of the smallpox vaccine in Napoleonic France, as recorded in contemporary medals.
    Vaccine. 2024 May 3:S0264-410X(24)00503-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
54. CHRISTOU-ERGOS M, Bleicher K, Leask J
    Factors associated with vaccination intention and uptake over time in a sample of older Australians.
    Vaccine. 2024 May 3:S0264-410X(24)00508-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
55. ADINUGROHO I, Stafford T, Bentall RP
    The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK.
    Vaccine. 2024 May 3:S0264-410X(24)00510-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
56. ANDREJKO KL, Gierke R, Rowlands JV, Rosen JB, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study.
    Vaccine. 2024 May 3:S0264-410X(24)00499-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
57. MAJE BELLO A, Chaimongkolnukul K, Poomputsa K, Mekvichitsaeng P, et al
    Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease.
    Vaccine. 2024 May 4:S0264-410X(24)00526-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.